Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule
SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced...
Mental Health
Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
Click here to register for November 14 investor webcastCompany plans to file its Earnings Report on November 14, 2023 on...
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
Company Introduces Multimedia Resources to Bring Awareness of SADLAVAL, QC / ACCESSWIRE / November 8, 2023 / As daylight saving...
ReflexAI Introduces HomeTeam to Revolutionize Veteran Mental Health Support
The first-of-its-kind, AI-powered training tool launches ahead of Veterans Day with the goal of improving the lives of veterans across...
futuresTHRIVE Launches Game-Changing AI Platform to Transform Youth Mental Health Screening
Insights from Recent Research Study Expose Significant Gaps in Standard of CareDARIEN, Conn., Nov. 08, 2023 (GLOBE NEWSWIRE) -- futuresTHRIVE,...
eClinicalWorks Cloud EHR Improves Operational Efficiency for 134-Provider Federally Qualified Health Center
CA-based practice sees success and improved patient engagement with the multi-dimensional eClinicalWorks V12WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the largest ambulatory cloud EHR,...
Takeda Announces Late-Breaking Data from Phase 2b Study of TAK-279, an Investigational, Oral, Once-Daily TYK2 Inhibitor, in Patients with Active Psoriatic Arthritis at American College of Rheumatology Convergence Annual Meeting
− The Study Met Its Primary Endpoint with 53.3% and 54.2% of Patients Treated With TAK-279 (15 mg and 30...
REMINDER: Jaguar Health to Host Virtual Educational Webinar on Rare Intestinal Failure Diseases with Leading Gastroenterologists and Nutrition Experts November 8th from 1:00 PM to 2:30 PM EST
Click here to register for webinarSAN FRANCISCO, CA / ACCESSWIRE / November 7, 2023 / Napo Pharmaceuticals (Napo), a Jaguar...
Innovative Renal Care and DeLorean AI Forge Historic Partnership to Revolutionize Kidney Care With Artificial Intelligence
Pioneering AI-Driven Patient Care to Elevate Outcomes and Transform Lives in the Dialysis SpaceMIAMI, FL / ACCESSWIRE / November 7,...
StageZero Life Sciences’ Clinical Business Introduces Fourth Pillar to Cancer Offerings
Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patientsTORONTO, ON / ACCESSWIRE / November 7, 2023...
Curated’s Latest Empowering Initiative: Complimentary Discovery Calls Supporting Individuals on Their Psychedelic Healing Journey
NEW YORK, NY / ACCESSWIRE / November 6, 2023 / Curated Mental Health is thrilled to announce an empowering initiative...
Red Light Holland Engages Dr. Taras Nahirny, as Medical Advisor, to Help with Distribution of Company’s Homogenized Psilocybin Microdosing Capsules and Help Advocate for Easier, but Regulated Access in Canada
Toronto, Ontario--(Newsfile Corp. - November 2, 2023) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
First Stop Health Announces Acquisition of SentryHealth
The virtual care providers' solutions will bring greater value to employer-clients and members with their steadfast dedication to delivering value-based...
Jaguar Health Enters Exclusive Crofelemer Revenue Sharing License and Commercialization Agreement with Quadri Pharmaceuticals Store for Rare Intestinal Failure Diseases in Middle East Markets
Quadri Pharma will cover 50% of the costs of development activity up to a capped dollar contributionJaguar to host virtual...
Rising Diagnosis and Treatment Rates of ADHD in Canadian Adults: Dr. Gurdeep Parhar, MD, Provides Historical Perspective and Current Insights
Attention Deficit Hyperactivity Disorder (ADHD) is Not a Rare Condition as Five Percent of Canadian Adults (1 in 20) Have...
Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
Top line results expected in the coming weeks for company's phase 3 OnTarget trial of crofelemer for preventative treatment of...
Amwell® Partners With Discovery Health to Bring First-of-its-Kind Digital Mental Health Benefit to South Africa
BOSTON & JOHANNESBURG--(BUSINESS WIRE)--Discovery Health, the leading health insurance administrator providing administration and managed care services to more than 3.8...
Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company’s FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDASAN...
Mydecine Innovations Group Announces Listing on the Canadian Securities Exchange and Delisting from the NEO
VANCOUVER, British Columbia, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NF0)...
Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
VANCOUVER, BC / ACCESSWIRE / October 5, 2023 / MindBio Therapeutics Corp. (CSE:MBIO);(Frankfurt:WF6), (the "Company" or "MindBio"), is pleased to...